drugset / Trial / NCT00795262

Effects of Quinapril 40 mg With Alpha Lipoic Acid or Placebo on Diabetes and Hypertension

NCT00795262

Completed 23 enrolled InVasc Therapeutics, Inc.
RandomizedCrossoverQuadruple-blindTreatment

Summary

We will evaluate the combination of quinapril and alpha lipoic acid in patients with diabetes mellitus and hypertension. We will determine whether the combination of quinapril and lipoic acid as compared to quinapril and placebo provides benefit on systemic blood pressure and proteinuria.

Timeline

Start
2008-07
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator alpha-lipoic acid Small molecule 600 mg
Comparator Quinapril Small molecule 40 mg